Voltage-gated calcium channels (VGCCs) are transmembrane proteins that translate electrical activities into intracellular calcium elevations and downstream signaling pathways. They serve essential physiological functions including communication between nerve cells, muscle contraction, cardiac activity, and release of hormones and neurotransmitters. Asparagine-linked glycosylation has emerged as an essential post-translational modification to control the number of channels embedded in the plasma membrane but also their functional gating properties. This review provides a comprehensive overview about the current state of knowledge on the role of glycosylation in the expression and functioning of VGCCs, and discusses how variations in the glycosylation of the channel proteins can contribute to pathological conditions.
Introduction
Calcium ion (Ca 2+ ) is an essential signaling molecule responsible for a plethora of cellular functions. In order to make use of the Ca 2+ signal, cells have developed complex yet fundamentally essential machinery so-called the Ca 2+ signaling toolkit [1] . Indeed, cell "well-being" is only possible with a strict timely and localized control of intracellular Ca 2+ concentrations. In excitable cells, voltage-gated Ca 2+ channels (VGCCs) have emerged as key players responsible for translating electrical membrane depolarizations into intracellular Ca 2+ elevations. VGCCs are large proteins (around 250 kDa) embedded in the plasma membrane of most excitable cells. They are comprised of a poreforming subunit (Ca v α 1 ) that consists of four domains each containing six transmembrane segments, connected with intracellular and extracellular linkers, and responsible for the Ca 2+ permeability and selectivity [2, 3] . In addition to the main pore-forming subunit, high voltage-activated Ca 2+ channels (HVA, Ca v 1. x and Ca v 2. x) associate with a number of ancillary subunits namely Ca v β, Ca v α 2 δ, and in some circumstances Ca v γ, which are essential for cell surface expression and gating of the channel [4] . In contrast, these ancillary subunits have little, if any, influence on low-voltage-activated channels (LVA, Ca v 3. x) [5] [6] [7] .
The regulation of VGCCs occurs via a myriad of signaling pathways that are essential to fine-tune their expression and activity [8] [9] [10] [11] . Post-translational modifications are recognized to play important regulatory roles on VGCCs. For instance, phosphorylation [12] [13] [14] [15] , ubiquitination [16] [17] [18] [19] [20] as well as S-palmitoylation [21, 22] were reported to significantly impact the functioning of VGCCs. In recent years, asparagine (N)-linked glycosylation has emerged as an essential modulator of ion channels, providing an additional level of control over the expression and functioning of the channel proteins [23] . In this review, we provide a comprehensive overview of the role of N-glycosylation in the maturation, trafficking, and functional expression of VGCCs, and discuss the potential implications in disease states.
N-glycosylation in protein biogenesis and sorting
N-glycosylation, as opposed to glycation, is an enzymatic process that relies on the activity of various enzymes acting all the way long the glycosylation pathway [24] . It consists in the orchestral building of an oligosaccharide tree (glycan) to an asparagine (N) residue in a consensus motif N-X-S/T (X being any amino acid) within the target protein. However, the presence of this consensus locus does not always lead to glycosylation that can be influenced by a number of factors including the location of this sequence within the target protein and the nature of the X residue [25, 26] . N-glycosylation is initiated in the endoplasmic reticulum (ER), where the oligosaccharide precursor is transferred from the dolichol donor onto the asparagine residue of the target protein (for review see [27] ). Trimming of the terminal glucose residues within the immature N-glycan allows the nascent polypeptide chain to interact with a number of ER resident chaperon proteins including calnexin and calreticulin. This interaction is essential for the proper folding of newly synthesized proteins and represents a checkpoint for quality control that determines the fate of the protein [28, 29] . While repeated addition/trimming of new glucose moieties allows the protein to reenter the calnexin/calreticulin cycle, misfolded proteins are in contrast directed to the ER associated degradation (ERAD) pathway. Correctly folded proteins that enter the secretory pathway undergo additional maturation of the glycan tree in the Golgi apparatus including branching and additional chemical modifications such as addition of sialic acid moieties, and resulting in bisecting, hybrid, and complex glycan structures [30, 31] (Fig. 1) . The composition of the oligosaccharide structure represents an important readout that determines the delivery of the protein to its final destination [32, 33] . We note that all of these aspects have been extensively reviewed in the recent years and readers interested in additional details on the role of N-glycosylation in the biogenesis and trafficking of proteins are redirected to some of the recent reviews [34, 35] .
N-glycosylation of the Ca v α 1 pore-forming subunit
Based on amino-acid sequence analysis, canonical N-glycosylation sites are virtually present in all of the ten mammalian VGCC isoforms ( Fig. 2) . In this section, we summarize our current knowledge of the glycosylation of the Ca v α 1 pore-forming subunit of VGCCs. Fig. 1 . Biosynthesis and processing of N-linked glycosylation. The N-glycosylation process is initiated at the membrane of the endoplasmic reticulum (ER) with the assembly of nucleotideactivated sugar precursors onto the lipid carrier dolichol by specific glycosyltransferases. The preliminary oligosaccharide is then flipped across the ER membrane and further enlarged by additional sugar species creating a branched oligosaccharide. The oligosaccharide is subsequently transferred to the asparagine residue within a consensus motif (N-X-S/T) to the nascent polypeptide chain by the oligosaccharytransferase complex (OST). The oligosaccharide is further modified in the ER and Golgi apparatus where it can be trimmed or refined, for example by addition of a terminal sialic acid moiety.
Ca v 1.x or L-type channels
Early studies using antibody and lectin-gold labeling identified glycosylation sites in the skeletal Ca v 1.1 channel [36] . However, it is lately that the role of N-glycosylation in the functioning of L-type channels was assessed. Detailed information on the glycosylation of the cardiac/ neuronal Ca v 1.2 channel was recently documented. Four potential Nglycosylation sites are present in the rabbit Ca v 1.2 channel and located in the domain I (N124 and N299) and domain IV (N1359 and N1410). While disruption of individual N-glycosylation sites had no significant effect on the functioning of the channel, concomitant disruption of the two glycosylation motifs located in the first domain by replacing the asparagine residues by a glutamine (double mutant N124Q/N299Q) caused a depolarizing shift of the voltage-dependence of activation of the channel expressed in Xenopus oocytes [37] . In addition, disruption of the two additional sites (quadruple mutant N124Q/N299Q/ N1359Q/N1410Q) located in the fourth domain of Ca v 1.2 led to a substantial reduction of the surface expression of the glycosylation-deficient channel and a decreased current density [37] (Figs. 2 and 3). These results support the notion that N-glycosylation of Ca v 1.2 serves distinct roles in the expression of the channel protein at the cell surface and also in the control of the gating properties of the channel.
Ca v 3.x or T-type channels
Although it is recently that glycosylation of T-type channels was investigated, indications for the existence of major post-translational modifications of the channel proteins emerged from earlier studies. For instance, initial biochemical analysis of Ca v 3.1 and Ca v 3.3 have revealed significant differences in the apparent molecular mass of the protein between brain regions, and also during neuronal development. Indeed, a 20 KDa differential was observed between the mouse forebrain (240 kDa) and the cerebellum Ca v 3.1 (260 kDa) [38] . Similar observations from western blot analysis of Ca v 3.3 channels indicated that the mouse midbrain and diencephalon expressed a 230 kDa and 190 kDa variants, whereas other brain regions only expressed the small product [38] . In addition to brain regional differences, developmental changes were observed. For instance, a high molecular weight Ca v 3.3 (260 kDa) is predominantly expressed at birth and is gradually replaced by a relative lower molecular product during neuronal development [38] . Additional studies revealed that these differentials are normalized after enzymatic deglycosylation of the channel protein with PNGase F, suggesting that brain regional and developmental changes in the apparent molecular weight are essentially caused by variable degrees of glycosylation of the channel protein [39] . However, it is lately that the functional significance of N-glycosylation on the functioning of T-type channels was investigated. Recently, we and others reported a detailed characterization of the glycosylation of Ca v 3.2 channels [40, 41] . Four potential glycosylation motifs are present within the human Ca v 3.2 channel and are located in the first (N192 and N271), third (N1466) and fourth membrane domain (N1710) (Fig. 2) . While enzymatic deglycosylation of Ca v 3.2 expressed in tsA-201 cells produced an overall substantial decrease of the T-type conductance, detailed analysis of individual glycosylation loci using site directed mutagenesis revealed more subtle and specific roles of the glycan tree in the expression and functioning of the channel. For instance, disruption of glycosylation sites at asparagine residues N271 and N1710 caused an almost complete loss of the expression of Ca v 3.2 suggesting an essential role for these glycosylation loci in the channel biogenesis [42] . In contrast, glycosylation at asparagine residues N192 and N1466 were found essential for proper expression and stability of the channel at the plasma membrane [42, 43] . In addition to control surface expression of Ca v 3.2, glycosylation at asparagine N192 and N1466 was found to influence the gating of the channel by modulating the Ca 2+ permeability and/or opening probability of the channel [44] . We note that the N192 residue is located right downstream the histidine residue H191 that support metal/redox modulation of Ca v 3.2 channels [45] [46] [47] . This indicates that the outer IS3-IS4 loop of Ca v 3.2 not only supports Nglycosylation-dependent modulation of the channel but form a molecular hub for multiple regulatory pathways that may play an essential role in fine-tuning the activity of the channel.
Altogether, these data revealed that not only the nature but also the specific location within the target protein defines the functional role of the glycan tree to differentially control the expression and functioning of the channel. This aspect is further discussed in the last section of this review when considering the role of glycosylation in pathological conditions.
N-glycosylation of ancillary subunits
The first indication for ancillary subunit glycosylation arose from initial studies aimed at investigating the molecular composition of the dihydropyridine receptor in skeletal muscle, where the apparent mass of Ca v α 2 δ and γ subunits was reduced upon glycosidase treatment [48] .
Ca v α 2 δ subunit
The Ca v α 2 δ subunit is an integral component of the Ca 2+ channel complex essential for proper surface trafficking and function of the channel [49, 50] . Ca v α 2 δ derives from a single gene and subsequently undergoes a post-translational cleavage generating α 2 and δ peptides, which remain associated with each other via disulphide bonds. While Ca v α 2 δ is mostly extracellular, it remains anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) moiety attached to the Cterminal region of the δ domain [51] . Ca v α 2 δ is by far the most extensively glycosylated constituent of the Ca 2+ channel complex and the glycan accounts for about a third of the total molecular weight of the protein [52] . Initial reports suggested that N-glycosylation of Ca v α 2 δ might play a role in stabilizing its interaction with the pore-forming Ca v α 1 subunit of the channel. This notion was further supported by the observation that Ca v α 2 δ-dependent potentiation of the Ca 2+ current was abolished upon enzymatic deglycosylation of the ancillary subunit [53] . More detailed analysis where strategic glycosylation sites within Ca v α 2 δ-1 were disrupted by site-directed mutagenesis revealed that glycosylation at asparagine residues N136 and N184 is essential for functional expression of Ca v 2.2 channels [54] . Similar observations were reported for Ca v 1.3 channels, suggesting that modulation of the expression of the channel complex by glycosylation of Ca v α 2 δ-1 may be a general mechanism that exists across various channel isoforms [55] . However, it remained elusive whether this effect was mediated by an altered trafficking of the channel complex to the cell surface, or by a direct modulation of the channel activity. More recently, the importance of N-glycosylation on the trafficking of Ca v α 2 δ-1 was extensively analyzed. Tetreault and colleagues worked out a number of additional glycosylation sites within the Ca v α 2 δ-1 and demonstrated that glycosylation at asparagine N633 is essential for proper expression of the subunit at the cell surface [56, 57] . In addition, and consistent with the chaperone role of Ca v α 2 δ-1 in the trafficking of the channel complex, Ca v 1.2 currents were virtually abolished when expressed in HEK-293 cells with the glycosylation-deficient Ca v α 2 δ-1 N633Q mutant. A similar effect was observed for several other mutants indicating that other glycosylation loci also contribute to the expression of Ca v α 2 δ-1 at the cell surface. In contrast, while glycosylation at asparagine N136 and N184 was found essential for functional expression of Ca v 2.2 channels [54] , it had little influence on the surface expression of Ca v α 2 δ-1 [56] . Considering that these glycosylation loci are located within the VWA-N region of Ca v α 2 δ-1, and that the VWA domain contributes to the interaction of Ca v α 2 δ-1 with the Ca v α 1 subunit [58, 59] , it is a possibility that reduced functional expression of Ca v 2.2 channels in the presence of glycosylation-deficient Ca v α 2 δ-1 N136Q and N184Q mutants may have resulted from a loss of interaction with the channel, disrupting the trafficking of Ca v α 2 δ-1 with Ca v 2.2 and/or altering the functional modulation of the channel. Consistent with this notion, disruption of the glycosylation site at asparagine N348 within the VWA domain of Ca v α 2 δ-1 significantly altered expression of Ca v 1.2 channels [56] . We note that a number of glycosylation loci within Ca v α 2 δ-1 are located in the vicinity of the pharmacological site of action of the antiepileptic/analgesic gabapentin drug [52, 60] and may have important influence on the pharmacology of the channel, although this notion remains to be explored.
Overall, N-glycosylation of Ca v α 2 δ-1 is undoubtedly an essential process contributing to expression and modulation of high-voltage activated Ca 2+ channels ( Fig. 3) and further studies will certainly decipher the exact underlying mechanisms taking place in this interplay.
Ca v γ subunit
The ancillary Ca v γ subunit is present in some channel complexes and associates with the Ca v α 1 pore-forming subunit, modulating essentially the gating of the channel. Initially described as part of the dihydropyridine complex in skeletal muscles [48] , the Ca v γ subunit was later identified as an integral component of various neuronal and cardiac channel complexes. It consists of four transmembrane segments, the first extracellular loop connecting the first and second segment containing at least one consensus N-glycosylation locus [61] . However, there is yet limited information on the functional role of glycosylation of the Ca v γ subunit. Using a similar disruptive molecular strategy as described above, it was reported that mutation of the asparagine residue N48 within the Ca v γ 2 subunit prevents the trafficking of the protein to the cell surface, and abolishes its role as a mediator for cell-cell adhesion [62] . However, despite its reduced expression at the cell surface, disruption of asparagine N48 was not sufficient to abolish the inhibitory role of Ca v γ on the functioning of Ca v 2.2 channels, suggesting that N-glycosylation and cell surface expression of Ca v γ 2 is not essential for the modulation of the channel [63] . In addition, the deglycosylated Ca v γ subunit retained its ability to biochemically interact with Ca v 1.1 channels, indicating that glycosylation is not required for the interaction of Ca v γ with the channel complex [64] . Others reported that inhibition of glycosylation with tunicamycin produced a hyperpolarizing shift of the steady-state inactivation of Ca v 1.2 channels only in the presence of Ca v γ 1 [65] . However, even though tunicamycin-induced alteration of Ca v 1.2 gating requires the presence of Ca v γ 1 , molecular disruption of N-glycosylation loci within the Ca v γ 1 subunit did not reproduce the effect [65] . We note that the use of tunicamycin is likely to affect all N-glycosylated proteins and it is thus important to consider the possibility that the effects observed on the functioning of the channel may have resulted from a more global alteration of the glycosylation of the proteome than from the channel subunits per se.
Altogether, and in contrast to what was reported for Ca v α 1 and Ca v α 2 δ subunits, glycosylation of Ca v γ plays a role in the surface trafficking of the protein but has little influence on the regulation of the channel (Fig. 3) .
Potential implications of glycosylation of VGCCs in diseased conditions
Defect in glycosylation of voltage-gated Na + and K + channels was implicated in a number of congenital disorders including long QT syndrome, cystic fibrosis, and Varitint-Waddler phenotype (for review see [66] ). In contrast, and despite the broad implication of VGCCs in numerous neuronal, cardiac, and immune disorders [67] [68] [69] , the role of glycosylation in the physiopathology of VGCCs has remained largely overlooked. Recently, altered glycosylation of Ca v 3.2 channels has emerged as a potential mechanism contributing to painful peripheral neuropathy associated with diabetes. It is well established that Ca v 3.2 channels are essential contributors to the initiation and maintenance of the pain signal [70] [71] [72] [73] , and contribute to synaptic transmission in the dorsal horn or the spinal cord [74] possibly by interacting with some of the proteins of the vesicular release machinery of neurotransmitters [75, 76] . In addition, increased expression of Ca v 3.2 channels in primary afferent fibers was documented in various types of chronic and neuropathic pain [77] [78] [79] including painful diabetic neuropathy [80] [81] [82] [83] [84] [85] [86] [87] . Although a number of signaling pathways and cellular mechanisms contribute to the expression of Ca v 3.2 channels [17, 88, 89] , our group recently demonstrated that chronic elevation of extracellular glucose levels in a range consistent with diabetic hyperglycemia significantly increased surface expression of Ca v 3.2 both in tsA-201 cells and in primary DRG neurons in culture by promoting the trafficking of the channel to the plasma membrane [42, 43] . Most importantly, increased expression of Ca v 3.2 channels in diabetic-like conditions was not observed when N-glycosylation at specific residues (N192 and N1466) was disrupted, suggesting that glycosylation is required for glucose-dependent potentiation of Ca v 3.2 channels [42, 43] (Fig. 4) . Although the mechanism by which glucose influence N-glycosylation is not fully understood, recent studies reported that decreased external glucose level is associated with a reduced availability of a number of glycosylation precursors and altered structure of protein N-glycan [90, 91] . This regulation may be particularly important in nerve cells where the uptake of glucose relies on insulin-independent glucose transporters GLUT1 and GLUT8 and directly depends on extracellular glucose levels (for review see ( [92] ). In addition, increased activity of glycan processing enzymes was reported in vitro and in vivo in animal models of diabetes [93] . Consistent with the notion that altered glycosylation of Ca v 3.2 may contribute to the enhanced T-type current in DRG neurons during diabetes, the group of Todorovic elegantly reported that peripheral injection of neuraminidase in vivo in a rodent model of diabetes is sufficient to reverse T-type-dependent painful neuropathy [41] . Hence, current data strongly support the notion that N-glycosylation is a key modulator of Ca v 3.2 channel expression in diabetic conditions and is necessary for glucose-driven up-regulation of Ca v 3.2 channels. In addition, decreased expression of Ca v 3.3 channels was reported with loss-of-function mutations in CACNA1I associated with schizophrenia [94] . Considering that these mutations are located in the vicinity of canonical glycosylation loci, it was proposed that altered expression of Ca v 3.3 channel might have resulted from a defective glycosylation of the channel protein.
Although the implication of N-glycosylation in the development of VGCC-associated pathologies is a new notion, emerging evidence indicate that altered glycosylation of the channel proteins may contribute to a number of congenital and chronic conditions.
Conclusion and perspectives
Voltage-gated Ca 2+ channels are undeniably essential contributors to a wide range of physiological functions, including nerve cell communication, muscle contraction, regulation of cardiac function, and release of hormones and neurotransmitters. Therefore, disturbance in their functioning are responsible for a number of chronic and congenital disorders. N-glycosylation has emerged as an important post-translational modification not only controlling the expression and intrinsic functioning of VGCCs, but also mediating environment-dependent modulation of the channels. In addition, there is emerging evidence for a role of glycosylation in the pathogenesis of VGCCs. Mutations in the genes encoding for VGCCs may represent one of the primary cause of altered glycosylation of the channel proteins. In addition, glycosylation-dependent regulation of ion channels can be influenced by various factors Fig. 4 . Crosstalk between glucose and N-glycosylation in Ca v 3.2 channel expression. In normal condition, the steady-state expression of glycosylated Ca v 3.2 channels at the cell surface is defined by the number of channels coming to and getting removed from the plasma membrane (middle panel). Glycosylation-deficient channels do traffic to the cell surface but their stability in the plasma membrane is decreased and get internalized faster (red arrow), leading to a decreased channel density at the cell surface (left panel). In contrast, elevated extracellular glucose levels significantly accelerates the trafficking of the channel to the cell surface (green arrows) without affecting its membrane stability, causing an increased channel density in the plasma membrane, which is believed to contribute to the development of painful diabetic neuropathy (right panel). Note that glucose-dependent potentiation of Ca v 3.2 channel expression relies on the proper glycosylation of the channel protein.
influencing the complex glycosylation pathway. For instance, the availability of monosaccharide [95] , dolichol [96] , or alteration in the activity of glycosidases [93] , are all factors that may influence the glycosylation of the channel protein. In that respect, evaluation of the chemical composition of the glycan tree in normal and pathological conditions represents an important challenge in the fine understanding of the role of glycosylation in diseased states. In addition, genetic mutations in key genes of the glycosylation machinery are responsible for a growing number of congenital disorders of glycosylation (CDG) [97, 98] . Although alteration in the glycosylation pathway likely represents the primary cause of these disorders, phenotypical manifestation most certainly relies on altered glycosylation of downstream target proteins possibly including ion channels. Hence, there is increased interest in identifying the molecular factors and pathways responsible for the glycosylation of VGCCs. This may uncover tremendous opportunities for rational design of new therapeutically relevant drugs targeting glycosylation of VGCCs and associated disorders, and possibly other channelopathies.
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